정규장
로그인 회원가입
PHG
PHG
Koninklijke Philips NV ADR
7월 27일 2:40 PM ET (한국 7/28 03:40)
$26.17
+0.14 ▲ +0.54%

필립스(PHG) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$25.4B
미드캡
P/E
22.4
적정 수준
배당수익률
3.81%
52주 위치
13%
저점 +4% · 고점 -22%
애널리스트
매수
D
Fundamental health
vs. Medical Devices
수익성 ⓘ
Top 48%
성장 ⓘ
Top 63%
밸류에이션 ⓘ
Top 73%
재무 안정 ⓘ
Top 60%
Index ⓘ -P/E ⓘ 22.45EPS (ttm) ⓘ 1.17Insider Own ⓘ -Shs Outstand ⓘ 971.3MPerf Week ⓘ -2.89%
Market Cap ⓘ 25.42BForward P/E ⓘ 13.33EPS next Y ⓘ 11.5%Insider Trans ⓘ -Shs Float ⓘ 971.3MPerf Month ⓘ -2.1%
Enterprise Value ⓘ 31.79BPEG ⓘ 2.43EPS next Q ⓘ 0.4Inst Own ⓘ 5.17%Short Float ⓘ 0.17%Perf Quarter ⓘ -5.28%
Income ⓘ 1.12BP/S ⓘ 1.24EPS this Y ⓘ -5.25%Inst Trans ⓘ -0.99%Short Ratio ⓘ 1.47Perf Half Y ⓘ -12%
Sales ⓘ 20.45BP/B ⓘ 1.9EPS next 5Y ⓘ 5.48%ROA ⓘ 3.69%Short Interest ⓘ 1.69MPerf YTD ⓘ -3.36%
Book/sh ⓘ 13.79P/C ⓘ 8.51EPS past 3/5Y ⓘ - -4.98%ROE ⓘ 8.7%52W High ⓘ -21.73% ($33.44)Perf Year ⓘ 1.28%
Cash/sh ⓘ 3.07P/FCF ⓘ 11.57Sales past 3/5Y ⓘ 2.42% 0.39%ROIC ⓘ 5.33%52W Low ⓘ 4.26% ($25.10)Perf 3Y ⓘ 25.82%
Dividend Est. ⓘ $1 (3.81%)EV/EBITDA ⓘ 9.91EPS Y/Y TTM ⓘ 244.86%Gross Margin ⓘ 45.19%Volatility(W/M) ⓘ 1.58% 1.51%Perf 5Y ⓘ -41.02%
Dividend TTM ⓘ 0.99EV/Sales ⓘ 1.55Sales Y/Y TTM ⓘ -Oper. Margin ⓘ 9.37%ATR (14) ⓘ 0.55Perf 10Y ⓘ 10.52%
Dividend Ex-Date ⓘ 2026/5/13Quick Ratio ⓘ 0.9EPS Q/Q ⓘ 113.83%Profit Margin ⓘ 5.49%RSI (14) ⓘ 42.68Recom ⓘ 2.19
Dividend Gr. 3/5Y ⓘ - 0.73%Current Ratio ⓘ 1.32Sales Q/Q ⓘ 5.95%SMA20 ⓘ -3.35% ($27.08)Beta ⓘ 0.74Target Price ⓘ $31.85
Payout ⓘ 78.73%Debt/Eq ⓘ 0.71Earnings ⓘ 2026/7/28SMA50 ⓘ -1.68% ($26.62)Rel Volume ⓘ 0.72Prev Close ⓘ $26.03
Employees ⓘ 66401LT Debt/Eq ⓘ 0.6EPS/Sales Surpr. ⓘ 17.57% 2.19%SMA200 ⓘ -6.2% ($27.9)Avg Volume(3M) ⓘ 1.15MPrice ⓘ $26.17
IPO ⓘ 1980/3/17Option/Short ⓘ Yes/YesTrades ⓘ 5759Volume ⓘ 827,017Change ⓘ 0.54%
Quarterly earnings trend Quarterly earnings data is not yet available — foreign-listed companies (ADRs) only file annual reports with the U.S., and recently listed companies may not have filed their first quarterly report.

📊 Koninklijke Philips NV ADR (PHG) Investment Analysis

What kind of company is Koninklijke Philips NV ADR?

필립스(PHG) 배당주
Healthcare · Medical Devices
#522 by Market Cap — Mid-Cap

🩺 A Netherlands-headquartered global health technology company that supplies medical imaging equipment—including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound—as well as image-guided therapy, patient monitoring, and personal health devices to markets worldwide. It trades on US exchanges in ADR form and is a core holding in the medical devices and digital health cycle.

Learn more about Koninklijke Philips NV ADR →
Market Cap
$25.4B
Approx. KRW 34.8 trillion
⚖️ 9% of Samsung Electronics
Market Cap Rank522
Employees66,401people
IPO1980/03/17
Current Price$26.17 ≈ 35,853원
NYSE · Netherlands

Key Events

⏰ Upcoming events
🔔 Earnings release D-1
7월 28일 (화) · 장 시작 전
예상 EPS $0.40
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🎯 Ex-div 2026년 5월 13일 (수)
🔔 Earnings release 2026년 5월 6일 (수) · 장 시작 전 EPS +17.6% 매출 +2.2%
🔔 Earnings release 2026년 2월 10일 (화) · 장 시작 전 EPS +26.6% 매출 +3.1%

Is it profitable?

Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
9.4%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Devices Median -23.9% · Top 22%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
5.5%
✓ 우수
My positionTop 25%
Low range Average High range
Medical Devices Median -34.5% · Top 22%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
45.2%
✓ 평균
My positionMid-range
Low range Average High range
Medical Devices Median 54.4% · Bottom 37%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
8.7%
✓ 평균
My positionMid-range
Low range Average High range
Healthcare 대형주 Median 11.9% · Bottom 40%
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
3.7%
✓ 평균
My positionMid-range
Low range Average High range
Healthcare 대형주 Median 5.1% · Bottom 38%
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
5.3%
✓ 평균
My positionMid-range
Low range Average High range
Healthcare 대형주 Median 7.4% · Bottom 40%
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
0.71
✓ Average
My positionMid-range
Low range Average High range
Medical Devices Median 0.39
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
1.32
✓ 평균
My positionMid-range
Low range Average High range
Medical Devices Median 2.91
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.90
✓ 평균
My positionMid-range
Low range Average High range
Medical Devices Median 2.09
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook
Positive and negative signals are mixed
애널리스트 목표가
$31.85
현재가 대비 +21.7%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
13.33배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
PEG (성장 반영 밸류)
2.43
고평가
💡 PEG > 2 — 성장 대비 비싼 편
내년 EPS 예상 성장률
+11.5%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
+5.5%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Reliability
Beat estimates in 2 of the last 2 quarters
2
예상 상회
0
예상 부합
0
예상 하회
100%
상회 비율
+42.3%
평균 서프라이즈
2026.05.06
상회
실적 $0.27 · 예상 $0.19 +42.8%
2026.02.10
상회
실적 $0.71 · 예상 $0.50 +41.8%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Average Growth
Mid-range within the industry
Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
-5.3%
부진
My positionBottom 25%
Low range Average High range
배당주 대형주 Median 5.5% · Bottom 22%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+11.5%
우수
My positionTop 25%
Low range Average High range
배당주 대형주 Median 7.3% · Top 22%
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
+5.5%
평균
My positionMid-range
Low range Average High range
배당주 대형주 Median 6.7% · Bottom 41%
📊 How much has it grown? (actual results)
Past 5-Year EPS
Actual average annual EPS growth over the past 5 years
-5.0%
부진
My positionBottom 25%
Low range Average High range
배당주 대형주 Median 6.3% · Bottom 18%
Past 5-Year Revenue
How much revenue grew over the past 5 years
+0.4%
부진
My positionBottom 25%
Low range Average High range
배당주 대형주 Median 6.7% · Bottom 10%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+6.0%
양호
My positionMid-range
Low range Average High range
배당주 대형주 Median 5.9% · Top 50%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -109%p below the market
PHG -41.0% · S&P 500 +68.0%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-109.0%p
Significantly behind the market
vs Health Care (XLV)
-64.7%p
Significantly behind the sector average
1-year basis
vs S&P 500
-15.2%p
behind the market
vs Health Care (XLV)
-18.5%p
behind the sector average
Rank among peers
5-year return Lowest among peers Based on 13 peers
1-year return Top 24% Based on 14 peers
Current position within 52-week range
Low (-4.3%p) High (-21.7%p)
Current price is 4.3% above the 52-week low and 21.7% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-23.3%
Annualized volatility
33.4%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴
Current diagnosis · 2026-07-24
Downtrend zone

Current price $26.17 below the midline ($27.08). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴
Current diagnosis · 2026-07-24
Bearish momentum holding

MACD -0.146 < Signal 0.013 in negative zone + Hist negative (-0.159). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴
Current diagnosis · 2026-07-24
Bearish zone

RSI 42.7 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 15.1.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Earnings·Vs. Assets·Vs. Sales·Vs. Cash Flow
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Cheap
🏢 Vs. Assets Cheap
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Cheap
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
22.45x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Devices median 30.60x · Around the industry average
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
13.33x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Devices median 17.57x · Around the industry average
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
1.90x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Devices median 2.58x · Around the industry average
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
1.24x
✓ Cheap
My positionMid-range
Low range Average High range
Medical Devices median 2.64x · Around the industry average
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
9.91x
✓ Very cheap
My positionTop 25%
Low range Average High range
Medical Devices median 14.42x · Top 25% — relatively cheap within the industry
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
11.57x
✓ Very cheap
My positionTop 25%
Low range Average High range
Medical Devices median 21.45x · Top 16% — relatively cheap within the industry
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$31.85 vs. current price +21.7%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Medical Devices

Who owns it?

Ownership is broadly stable
Institutional modest net selling -1.0% · Short interest light 0.2%
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-
No trading data for Insiders
🏦 Institutions (funds & investors)
-1.0%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 5.2%
Retail-led
Healthcare 대형주 Median 91.9%
🧑‍💼 Insiders 0.0%
Low, common among large-caps
Healthcare 대형주 Median 0.8%
👤 Retail investors (estimated) 94.8%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
0.2%
Low — limited short-side pressure
Healthcare 대형주 Median 3.6%
Past 89 days Little change
Short interest days to cover
1.5 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 971.3M주
Float (tradable shares) 971.3M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 89 days.

ETFs holding PHG

ETFs with the highest weightings · 10 total shown
HEAL
HEAL
Global X HealthTech ETF
5.17%
$28M
LGHT
LGHT
Langar Global HealthTech ETF
4.70%
$2M
MOTI
MOTI
VanEck Morningstar International Moat ETF
2.57%
$70M
EWN
EWN
iShares MSCI Netherlands ETF
2.56%
$575M
MDEV
MDEV
First Trust Indxx Medical Devices ETF
2.17%
$3M
* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

배당주 — 연 3.81% 배당
5년 배당 성장률 0.73%
Dividend Yield
3.81%
Industry average 1.25%
Dividend Per Share
$1.00
Annualized
Payout Ratio
79%
Share of net income paid as dividends
5-Year Growth
0.7%
Annualized dividend growth
📊 총 이력 1986~2025 (38건)
연도별 배당 총액 추이
주당 배당금을 연 단위로 합산한 금액입니다. 막대가 우상향이면 매년 배당이 늘어나고 있다는 뜻입니다.
$0.98 -1.6%
2013
$1.10 +11.8%
2014
$0.91 -17.2%
2015
$0.88 -2.9%
2016
$0.86 -2.3%
2017
$0.99 +14.9%
2018
$0.96 -3.2%
2019
$1.03 +7.6%
2021
$0.96 -6.7%
2022
$0.97 +0.3%
2025
$X.XX 그 해 총 배당금 +X% 전년 대비 증가 -X% 감소
최근 배당 이력 총 38건
아래로 스크롤하면 과거 배당 이력을 볼 수 있습니다.
배당락일
주당 금액
지급일
당시 수익률
2025-05-13
$0.967
—
3.99%
2022-05-12
$0.964
—
4.14%
2021-05-10
$1.03
—
1.83%
2019-05-13
$0.960
—
2.39%
2018-05-07
$0.992
—
4.43%
2017-05-12
$0.863
—
4.90%
2016-05-13
$0.883
—
3.54%
2015-05-08
$0.909
—
3.29%
2014-05-05
$1.10
—
6.65%
2013-05-07
$0.982
—
3.67%
2012-05-02
$0.998
—
5.33%
2011-04-04
$1.02
—
3.21%
2010-03-29
$0.951
—
5.73%
2009-03-30
$0.900
—
6.17%
2008-03-28
$1.02
—
4.82%
2007-03-30
$0.788
—
3.48%
2006-03-31
$0.537
—
3.14%
2005-04-01
$0.521
—
1.95%
2004-03-26
$0.442
—
2.94%
2003-03-28
$0.381
—
4.27%
2002-04-02
$0.314
—
1.04%
2001-03-30
$0.323
—
6.68%
2000-07-27
$1.18
—
3.36%
2000-04-05
$0.286
—
0.74%
1999-03-26
$0.274
—
1.66%
1999-03-17
$0.052
—
1.52%
1998-03-17
$0.244
—
2.49%
1997-03-24
$0.210
—
4.27%
1996-03-26
$0.246
—
3.22%
1995-05-03
$0.043
—
0.43%
1990-04-11
$0.156
—
6.81%
1989-12-11
$0.064
—
4.37%
1989-04-13
$0.140
—
7.75%
1988-12-12
$0.056
—
5.47%
1988-04-13
$0.157
—
5.90%
1987-12-10
$0.068
—
7.09%
1987-04-09
$0.144
—
3.25%
1986-12-15
$0.056
—
1.13%
* "배당락일"은 배당받으려면 이 날 이전에 주식을 보유해야 하는 기준일입니다. 지급일·당시 수익률은 일부 종목에서 데이터가 없을 수 있습니다.
💰 내가 100만원 투자한다면
연간 배당금 (세후) 3.2만원
5년 누적 (세후) 16.5만원
* 환율 1,370원, 세금 15% 반영. 5년 누적은 배당 성장률 연 0.73% 가정.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
PHG PHG This Stock
$25.4B22.4 ▲1.9 ▲8.7% ▲3.81% ▲+0.5%
LLY
$1.13T43.0 ▼36.2 ▼107.64% ▲0.58% ▼+0.9%
JNJ
$634.1B30.5 ▼7.5 ▼25.74% ▲2.04% ▲+1.6%
ABBV
$458.2B127.9 ▼- 15221.82% ▲2.65% ▲+0.9%
UNH
$382.1B27.1 ▼3.9 ▼12.49% ▲2.15% ▲-0.7%
MRK
$323.7B36.9 ▼7.1 ▼18.97% ▲2.49% ▲+0.5%
Sector Avg-25.82.7-48.83%1.25%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen
→

Related News & Content

📖 Company overview
필립스(PHG) 뭐하는 회사일까? - 주가 전망·실적·시총·관련주·본사 총정리
필립스(PHG)는 자기공명영상·컴퓨터 단층·초음파 등 의료 영상 장비와 디지털 헬스를 공급하는 네덜란드 본사 글로벌 헬스테크 기업의 미국 ADR로, 의료 기기 자본투자 사이클과 사업 포트폴리오 재편이 매출·관련주 주가의 핵심 동력입니다.
📚 Related Investment Guides
미국주식 세금 총정리 2026 — 초보자를 위한 계산법과 절세 전략
2026년 미국주식 세금 총정리. 양도소득세 22% 계산법, 배당세 15% 원천징수, 손익통산, 절세 전략까지. 실제 금액 시뮬레이션과 세금 계산기로 내 세금을 직접 확인해보세요.

FAQ

What kind of company is 필립스(PHG)?

필립스(PHG) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is the market cap of PHG?

The market cap of PHG is approximately $25.4B, ranking 522 within its sector.

Does PHG pay dividends?

PHG has a dividend yield of approximately 3.81%, with an annual dividend of $1.00.

What is the P/E ratio of PHG?

PHG has a P/E ratio of approximately 22.4x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for PHG?

PHG has recorded a 52-week high of $33.44 and a low of $25.10.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.